Pros and cons of a missing chemokine receptor-Comments on "Is the European spatial distribution of the HIV-1-resistant CCR5-Δ32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?" by Eric Faure and Manuela Royer-Carenzi (2008)

Infection, Genetics and Evolution

Volumn 9, Issue 4, 2009, Pages 387-389

  Vargas, Andréia Escosteguy ^a   Cechim, Giovana ^a   Correa, Juliana Ferraz ^a   Gomes, Patrícia Alcantara ^a   Macedo, Gabriel de Souza ^a   Medeiros, Rúbia Marília de ^a   Perotoni, Gabriel ^a   Rauber, Rafael ^a   Villodre, Emilly Schlee ^a   Chies, José Artur B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

EUROPE; GALLBLADDER CANCER; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE SYSTEM; LETTER; NONHUMAN; PANCREAS CANCER; POPULATION GENETICS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR IMMUNITY; VIRUS INFECTION;

ANIMALS; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENETIC VARIATION; HUMANS; IMMUNITY, INNATE; MICE; RECEPTORS, CCR5;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 68749120813     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.01.001     Document Type: Letter

References (29)

1. Barr E.L., Ouburg S., Igietseme J.U., Morré S.A., Okwandu E., Eko F.O., Ifere G., Belay T., He Q., Lyn D., Nwankwo G., Lillard J., Black C.M., and Ananaba G.A. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. J. Microbiol. Immunol. Infect. 38 (2005) 244-254
2. Carr D.J.J., Ash J., Lane T.E., and Kuziel W.A. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J. Gen. Virol. 87 (2006) 489-499
3. Chies J.A., and Hutz M.H. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz. J. Med. Biol. Res. 36 (2003) 71-75
4. Chies J.A., and Nardi N.B. Sickle cell disease: a chronic inflammatory condition. Med. Hypotheses 57 (2001) 46-50
5. Chiesa S., Prigione I., Morandi F., Buoncompagni A., Picco P., Bocca P., Martini A., Pistoia V., and Gattorno M. Cytokine flexibility of early and differentiated memory T helper cells in juvenile idiopathic arthritis. J. Rheumatol. 31 (2004) 2048-2054
6. Dawson T.C., Beck M.A., Kuziel W.A., Henderson F., and Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156 (2000) 1951-1959
7. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172 (2004) 6435-6443
8. Duell E.J., Casella D.P., Burk R.D., Kelsey K.T., and Holly E.A. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 726-731
9. Faure E., and Royer-Carenzi M. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?. Infect. Genet. Evol. 8 (2008) 864-874
10. Gade-Andavolu R., Comings D.E., MacMurray J., Rostamkhani M., Cheng L.S., Tourtellotte W.W., and Cone L.A. Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genet. Med. 6 (2004) 126-131
11. + memory T cells homing to the joints in juvenile idiophatic arthritis. Arthritis Res. Ther. 7 (2005) R256-R267
12. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., and Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202 (2005) 1087-1098
13. Glass W.G., McDermott D.H., Lim J.K., Lekhong S., Yu S.F., Frank W.A., Pape J., Cheshier R.C., and Murphy P.M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203 (2006) 35-40
14. Gómez-Reino J.J., Pablos J.L., Carreira P.E., Santiago B., Serrano L., Vicario J.L., Balsa A., Figueroa M., and de Juan M.D. Association of rheumatoid arthritis with a functional chemokine receptor CCR5. Arthritis Rheum. 42 (1999) 989-992
15. Hardison J.L., Wrightsman R.A., Carpenter P.M., Kuziel W.A., Lane T.E., and Manning J.E. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 74 (2006) 135-143
16. Khan I.A., Thomas S.Y., Moretto M.M., Lee F.S., Islam S.A., Combe C., Schwartzman J.D., and Luster A.D. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2 (2006) e49
17. Kindberg E., Mickiene A., Ax C., Akerlind B., Vene S., Lindquist L., Lundkvist A., and Svensson L. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J. Infect. Dis. 197 (2008) 266-269
18. Klein R.S. A moving target: the multiple roles of CCR5 in infectious diseases. J. Infect. Dis. 197 (2008) 183-186
19. Lim J.K., Louie C.Y., Glaser C., Jean C., Johnson B., Johnson H., McDermott D.H., and Murphy P.M. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J. Infect. Dis. 197 (2008) 262-265
20. Mañes S., Mira E., Colomer R., Montero S., Real L.M., Gómez-Moutón C., Jiménez-Baranda S., Garzón A., Lacalle R.A., Harshman K., Ruíz A., and Martínez A.C. CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J. Exp. Med. 198 (2003) 1381-1389
21. Pokorny V., McQueen F., Yeoman S., Merriman M., Merriman A., Harrison A., Highton J., and McLean L. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann. Rheum. Dis. 64 (2005) 487-490
22. + regulatory T cells in inflamed synovia. J. Exp. Med. 201 (2005) 1793-1803
23. Scheibel I., Veit T., Neves A.G., Souza L., Prezzi S., Machado S., Kohem C., Picarelli M., Xavier R., Brenol J.C., and Chies J.A. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. Scand. J. Rheumatol. 37 (2008) 13-17
24. Skendros P., Boura P., Tsantas N., Debre P., and Theodorou I. Frequency analysis of the CCR5delta32 mutation in patients with brucellosis. Scand. J. Infect. Dis. 34 (2002) 944-946
25. Srivastava A., Pandey S.N., Choudhuri G., and Mittal B. CCR5 D32 polymorphism: associated with gallbladder cancer susceptibility. Scand. J. Immunol. 67 (2008) 516-522
26. Srivastava P., Helms P.J., Stewart D., Main M., and Russell G. Association of CCR5D32 with reduced risk of childhood but not adult asthma. Thorax 58 (2003) 222-226
27. Thapa M., Kuziel W.A., and Carr D.J. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81 (2007) 3704-3713
28. Vargas A.E., da Silva M.A., Silla L., and Chies J.A. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens 66 (2005) 683-690
29. Yurchenko E., Tritt M., Hay V., Shevach E.M., Belkaid Y., and Piccirillo C.A. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203 (2006) 2451-2460